Cargando…
Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-mont...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354714/ https://www.ncbi.nlm.nih.gov/pubmed/25802515 http://dx.doi.org/10.1155/2015/672410 |
_version_ | 1782360784727179264 |
---|---|
author | Garcia, M. Domènech, X. Vidal, C. Torné, E. Milà, N. Binefa, G. Benito, L. Moreno, V. |
author_facet | Garcia, M. Domènech, X. Vidal, C. Torné, E. Milà, N. Binefa, G. Benito, L. Moreno, V. |
author_sort | Garcia, M. |
collection | PubMed |
description | Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-month follow-up (n = 30,480). We used hospital administration data to identify CRC. An interval cancer was defined as an invasive cancer diagnosed within 30 months of a negative screening result and before the next recommended examination. Gender, age, stage, and site distribution of interval cancers were compared with those in the screen-detected group. Results. Within the study period, 97 tumors were screen-detected and 74 tumors were diagnosed after a negative screening. In addition, 17 CRC (18.3%) were found after an inconclusive result and 2 cases were diagnosed within the surveillance interval (2.1%). There was an increase of interval cancers over the four rounds (from 32.4% to 46.0%). When compared with screen-detected cancers, interval cancers were found predominantly in the rectum (OR: 3.66; 95% CI: 1.51–8.88) and at more advanced stages (P = 0.025). Conclusion. There are large numbers of cancer that are not detected through fecal occult blood test-based screening. The low sensitivity should be emphasized to ensure that individuals with symptoms are not falsely reassured. |
format | Online Article Text |
id | pubmed-4354714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-43547142015-03-23 Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain Garcia, M. Domènech, X. Vidal, C. Torné, E. Milà, N. Binefa, G. Benito, L. Moreno, V. Gastroenterol Res Pract Research Article Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-month follow-up (n = 30,480). We used hospital administration data to identify CRC. An interval cancer was defined as an invasive cancer diagnosed within 30 months of a negative screening result and before the next recommended examination. Gender, age, stage, and site distribution of interval cancers were compared with those in the screen-detected group. Results. Within the study period, 97 tumors were screen-detected and 74 tumors were diagnosed after a negative screening. In addition, 17 CRC (18.3%) were found after an inconclusive result and 2 cases were diagnosed within the surveillance interval (2.1%). There was an increase of interval cancers over the four rounds (from 32.4% to 46.0%). When compared with screen-detected cancers, interval cancers were found predominantly in the rectum (OR: 3.66; 95% CI: 1.51–8.88) and at more advanced stages (P = 0.025). Conclusion. There are large numbers of cancer that are not detected through fecal occult blood test-based screening. The low sensitivity should be emphasized to ensure that individuals with symptoms are not falsely reassured. Hindawi Publishing Corporation 2015 2015-02-24 /pmc/articles/PMC4354714/ /pubmed/25802515 http://dx.doi.org/10.1155/2015/672410 Text en Copyright © 2015 M. Garcia et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Garcia, M. Domènech, X. Vidal, C. Torné, E. Milà, N. Binefa, G. Benito, L. Moreno, V. Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title | Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title_full | Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title_fullStr | Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title_full_unstemmed | Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title_short | Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain |
title_sort | interval cancers in a population-based screening program for colorectal cancer in catalonia, spain |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354714/ https://www.ncbi.nlm.nih.gov/pubmed/25802515 http://dx.doi.org/10.1155/2015/672410 |
work_keys_str_mv | AT garciam intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT domenechx intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT vidalc intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT tornee intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT milan intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT binefag intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT benitol intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain AT morenov intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain |